Чланци са овлашћеним јавним приступом - Anne H. CrossСазнајте више
Није доступно нигде: 7
Прегледајте
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind …
JR Corboy, RJ Fox, I Kister, GR Cutter, CJ Morgan, R Seale, ...
The Lancet Neurology 22 (7), 568-577, 2023
Овлашћења: Patient-Centered Outcomes Research Institute
Прегледајте
Effect of multiple sclerosis disease-modifying therapies on B cells and humoral immunity
EE Longbrake, AH Cross
JAMA neurology 73 (2), 219-225, 2016
Овлашћења: US National Institutes of Health
Прегледајте
Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica
JR Ciotti, NS Eby, GF Wu, RT Naismith, S Chahin, AH Cross
Multiple Sclerosis and Related Disorders 45, 102399, 2020
Овлашћења: US National Institutes of Health
Прегледајте
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis
F Aloisi, AH Cross
Journal of Neuroimmunology 371, 577935, 2022
Овлашћења: Government of Italy
Прегледајте
Active and progressive: a new duality of MS classification
AH Cross, DM Wingerchuk, BG Weinshenker
Neurology 83 (3), 206-207, 2014
Овлашћења: UK Medical Research Council
Прегледајте
Role of B cells in relapsing-remitting and progressive multiple sclerosis and long-term effects of B cell depletion
A Shirani, O Stuve, AH Cross
Neurologic Clinics 42 (1), 137-153, 2024
Овлашћења: US Department of Veterans Affairs
Прегледајте
Further support for rituximab in relapsing multiple sclerosis
RT Naismith, AH Cross
The Lancet Neurology 21 (8), 672-673, 2022
Овлашћења: Swedish Research Council
Доступно негде: 134
Прегледајте
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
Овлашћења: US National Institutes of Health, Research Foundation (Flanders), German …
Прегледајте
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
Овлашћења: US National Institutes of Health, Research Foundation (Flanders), Danish …
Прегледајте
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ...
Nature genetics 41 (7), 776-782, 2009
Овлашћења: US National Institutes of Health
Прегледајте
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, HJC McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
Овлашћења: British Heart Foundation, UK Medical Research Council, National Institute …
Прегледајте
Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis
MD Budde, M Xie, AH Cross, SK Song
Journal of Neuroscience 29 (9), 2805-2813, 2009
Овлашћења: US National Institutes of Health
Прегледајте
A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms
IY Choi, L Piccio, P Childress, B Bollman, A Ghosh, S Brandhorst, ...
Cell reports 15 (10), 2136-2146, 2016
Овлашћења: US National Institutes of Health, German Research Foundation
Прегледајте
Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota
F Cignarella, C Cantoni, L Ghezzi, A Salter, Y Dorsett, L Chen, D Phillips, ...
Cell metabolism 27 (6), 1222-1235. e6, 2018
Овлашћења: US Department of Defense, US National Institutes of Health
Прегледајте
Quantification of increased cellularity during inflammatory demyelination
Y Wang, Q Wang, JP Haldar, FC Yeh, M Xie, P Sun, TW Tu, K Trinkaus, ...
Brain 134 (12), 3590-3601, 2011
Овлашћења: US National Institutes of Health
Прегледајте
Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords
EC Klawiter, RE Schmidt, K Trinkaus, HF Liang, MD Budde, RT Naismith, ...
Neuroimage 55 (4), 1454-1460, 2011
Овлашћења: US National Institutes of Health
Прегледајте
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
Овлашћења: British Heart Foundation, Blood Cancer UK, UK Medical Research Council …
Прегледајте
The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study
AJ Solomon, DN Bourdette, AH Cross, A Applebee, PM Skidd, ...
Neurology 87 (13), 1393-1399, 2016
Овлашћења: US National Institutes of Health
Прегледајте
Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
L Piccio, C Buonsanti, M Cella, I Tassi, RE Schmidt, C Fenoglio, J Rinker, ...
Brain 131 (11), 3081-3091, 2008
Овлашћења: US National Institutes of Health
Прегледајте
Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis
A Salter, RJ Fox, SD Newsome, J Halper, DKB Li, P Kanellis, K Costello, ...
JAMA neurology 78 (6), 699-708, 2021
Овлашћења: US National Institutes of Health
Публикације и информације о финансирању аутоматски одређује рачунарски програм